Trial Profile
Investigation of SGLT2 inhibitors for normal glucose tolerance
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2015
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 18 Apr 2015 Status changed from not yet recruiting to discontinued as reported by University Hospital Medical Information Network - Japan
- 12 Jun 2014 New trial record